February 01, 2015 7:44 PM ET


Company Overview of Transcept Pharmaceuticals, Inc.

Executive Profile

Glenn A. Oclassen Sr.

Former Chief Executive Officer, President and Director, Paratek Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Mr. Glenn A. Oclassen, Sr. has been the Chief Executive Officer and President of Transcept Pharmaceuticals, Inc. (TPI) since July 2003 and has been its Chairman of the Board since December 31, 2013. Mr. Oclassen serves as Consultant of Connetics Corporation. He served as Chief Executive Officer and President at Paratek Pharmaceuticals, Inc. till October 30, 2014. He served as Venture Partner of Montreux Equity Partners, Montreux Equity Partners II, Montreux Equity Partners ...

Corporate Headquarters

1003 West Cutting Boulevard
Point Richmond, California 94804

United States

Phone: 510-215-3500
Fax: --

Board Members Memberships

Former Chief Executive Officer, President and Director
Former Director
Chairman of the Board, Chief Executive Officer and President


BS 1965
San Diego State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Transcept Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.